{"id":3776,"date":"2026-11-17T18:53:02","date_gmt":"2026-11-17T18:53:02","guid":{"rendered":"https:\/\/tansan.com.tr\/?page_id=3776"},"modified":"2026-11-17T20:29:55","modified_gmt":"2026-11-17T20:29:55","slug":"metastatik-meme-kanseri-tedavisinde-yeni-gelismeler","status":"publish","type":"page","link":"https:\/\/tansan.com.tr\/en\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/","title":{"rendered":"New Developments in the Treatment of Metastatic Breast Cancer"},"content":{"rendered":"<p>Meme kanserinin ba\u015fka organlara yay\u0131lmas\u0131, hastalar ve yak\u0131nlar\u0131 i\u00e7in pek \u00e7ok soruyu beraberinde getirir. Bug\u00fcn tedavide hedefimiz, hastal\u0131\u011f\u0131 m\u00fcmk\u00fcn oldu\u011funca uzun s\u00fcre kontrol alt\u0131nda tutmak, ya\u015fam s\u00fcresini uzatmak ve ki\u015finin g\u00fcnl\u00fck ya\u015fam\u0131n\u0131 korumakt\u0131r. Son y\u0131llarda artan se\u00e7enekler, tedaviyi t\u00fcm\u00f6r\u00fcn \u00f6zelliklerine ve daha \u00f6nce kullan\u0131lan ila\u00e7lara g\u00f6re daha ayr\u0131nt\u0131l\u0131 planlamam\u0131za olanak sa\u011fl\u0131yor. [1]\n<p>Tedavi se\u00e7imi, hastal\u0131\u011f\u0131 yeniden tan\u0131makla ba\u015fl\u0131yor. Uygun oldu\u011funda metastaz b\u00f6lgesinden biyopsi al\u0131narak hormon resept\u00f6rleri ve HER2 tekrar de\u011ferlendiriliyor; bu \u00f6zellikler zaman i\u00e7inde de\u011fi\u015febiliyor. Gerekti\u011finde t\u00fcm\u00f6r dokusunda veya kandan yap\u0131lan s\u0131v\u0131 biyopsiyle ESR1, PIK3CA, AKT1 ve PTEN gibi de\u011fi\u015fiklikler ara\u015ft\u0131r\u0131l\u0131yor. Kal\u0131tsal BRCA1\/2 incelemesi de uygun hastalarda PARP inhibit\u00f6rleri gibi se\u00e7eneklere yol g\u00f6sterebiliyor. Her test, sonucunun tedaviye katk\u0131s\u0131 d\u00fc\u015f\u00fcn\u00fclerek se\u00e7iliyor. [2]\n<p>Hormon resept\u00f6r\u00fc pozitif, HER2 negatif hastal\u0131kta hormon tedavisi ve CDK4\/6 inhibit\u00f6rleri bir\u00e7ok hasta i\u00e7in \u00f6nemli bir ba\u015flang\u0131\u00e7 yakla\u015f\u0131m\u0131 olmaya devam ediyor. Diren\u00e7 geli\u015fti\u011finde molek\u00fcler sonuca g\u00f6re hormon tedavisini de\u011fi\u015ftirmek veya PI3K\/AKT yolunu hedefleyen ila\u00e7lardan yararlanmak m\u00fcmk\u00fcn olabiliyor. 2026\u2019daki yeniliklerden biri, belirli hastalarda kanda ESR1 mutasyonu saptand\u0131\u011f\u0131nda, g\u00f6r\u00fcnt\u00fclemede ilerleme beklenmeden hormon tedavisinin kamizestranta de\u011fi\u015ftirilmesi ve CDK4\/6 inhibit\u00f6r\u00fcn\u00fcn s\u00fcrd\u00fcr\u00fclmesi. SERENA-6 verilerine dayanan bu yakla\u015f\u0131m ABD\u2019de h\u0131zland\u0131r\u0131lm\u0131\u015f onay ald\u0131; her hastada rutin uygulama anlam\u0131na gelmiyor. [2,3,8]\n<p>HER2 pozitif hastal\u0131kta antikora ba\u011fl\u0131 kemoterapiler tedavi s\u0131ralamas\u0131n\u0131 de\u011fi\u015ftiriyor. Trastuzumab derukstekan\u0131n pertuzumabla birlikte ilk basamakta kullan\u0131m\u0131, hastal\u0131\u011f\u0131n ilerlemeden kontrol alt\u0131nda kald\u0131\u011f\u0131 s\u00fcreyi uzatan sonu\u00e7lar\u0131n ard\u0131ndan ABD\u2019de onayland\u0131. Bu ila\u00e7 grubu, hedefe y\u00f6nelik antikorla kemoterapiyi birle\u015ftiriyor; tedavi s\u0131ras\u0131nda akci\u011fer iltihab\u0131 dahil yan etkiler a\u00e7\u0131s\u0131ndan yak\u0131n takip gerekiyor. [4]\n<p>HER2\u2019nin d\u00fc\u015f\u00fck veya \u00e7ok d\u00fc\u015f\u00fck d\u00fczeyde bulundu\u011fu t\u00fcm\u00f6rler de art\u0131k ayr\u0131 bir tedavi olana\u011f\u0131 a\u00e7\u0131s\u0131ndan de\u011ferlendiriliyor. Hormon resept\u00f6r\u00fc pozitif metastatik hastal\u0131kta, hormon tedavisi sonras\u0131nda ilerleme oldu\u011funda uygun HER2 d\u00fc\u015f\u00fck veya \u00e7ok d\u00fc\u015f\u00fck hastalar trastuzumab derukstekandan yararlanabiliyor. Bu nedenle patoloji raporundaki HER2 ayr\u0131nt\u0131s\u0131n\u0131n do\u011fru de\u011ferlendirilmesi \u00f6nem ta\u015f\u0131yor. [5]\n<p>\u00dc\u00e7l\u00fc negatif metastatik meme kanserinde de 2026\u2019da ilk basamak se\u00e7enekleri geni\u015fledi. Sacituzumab govitekan, PD-L1 d\u00fczeyi uygun hastalarda pembrolizumabla birlikte; PD-1\/PD-L1 tedavisine uygun olmayanlarda ise tek ba\u015f\u0131na ABD\u2019de onay ald\u0131. Ayn\u0131 gruptaki datopotamab derukstekan da PD-1\/PD-L1 tedavisine uygun olmayan hastalar i\u00e7in yeni bir se\u00e7enek oldu. Hangi ilac\u0131n se\u00e7ilece\u011fi, \u00f6nceki tedaviler ve ki\u015finin durumu birlikte de\u011ferlendirilerek belirleniyor. [6,7]\n<p>Yeni bir ilac\u0131n bulunmas\u0131 kadar, do\u011fru zamanda ve do\u011fru ki\u015fi i\u00e7in kullan\u0131lmas\u0131 da \u00f6nemli. Tedavinin beklenen yarar\u0131, yan etkileri ve T\u00fcrkiye\u2019deki eri\u015fim ko\u015fullar\u0131 a\u00e7\u0131k\u00e7a konu\u015fulmal\u0131. A\u011fr\u0131 kontrol\u00fc, beslenme, ruhsal destek ve hastan\u0131n kendi \u00f6ncelikleri de tedavinin ayr\u0131lmaz par\u00e7as\u0131 olarak ele al\u0131nmal\u0131.<\/p>\n<p><strong>Kaynaklar \u00a0<\/strong><a href=\"https:\/\/www.cancer.gov\/types\/breast\/hp\/breast-treatment-pdq\">[1] NCI \u00b7 Breast cancer<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.annalsofoncology.org\/article\/S0923-7534%2826%2900902-6\/fulltext\">[2] ESMO \u00b7 2026<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-grants-accelerated-approval-new-breast-cancer-treatment\">[3] Camizestrant \u00b7 FDA 2026<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/fda-approves-fam-trastuzumab-deruxtecan-nxki-pertuzumab-unresectable-or-metastatic-her2-positive\">[4] HER2 positive \u00b7 FDA<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.fda.gov\/drugs\/cancer-approvals\/fda-approves-fam-trastuzumab-deruxtecan-nxki-unresectable-or-metastatic-hr-positive-her2-low-or-her2\">[5] HER2 low \u00b7 FDA<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.fda.gov\/drugs\/cancer-approvals\/fda-approves-sacituzumab-govitecan-hziy-monotherapy-and-combination-pembrolizumab-first-line\">[6] Sacituzumab \u00b7 FDA 2026<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.fda.gov\/drugs\/cancer-approvals\/fda-approves-datopotamab-deruxtecan-dlnk-unresectable-or-metastatic-triple-negative-breast-cancer\">[7] Datopotamab \u00b7 FDA 2026<\/a>\u00a0\u00a0| \u00a0<a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2502929\">[8] SERENA-6 \u00b7 NEJM<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Meme kanserinin ba\u015fka organlara yay\u0131lmas\u0131, hastalar ve yak\u0131nlar\u0131 i\u00e7in pek \u00e7ok soruyu beraberinde getirir. Bug\u00fcn tedavide hedefimiz, hastal\u0131\u011f\u0131 m\u00fcmk\u00fcn oldu\u011funca uzun s\u00fcre kontrol alt\u0131nda tutmak, ya\u015fam s\u00fcresini uzatmak ve ki\u015finin g\u00fcnl\u00fck ya\u015fam\u0131n\u0131 korumakt\u0131r. Son y\u0131llarda artan se\u00e7enekler, tedaviyi t\u00fcm\u00f6r\u00fcn \u00f6zelliklerine ve daha \u00f6nce kullan\u0131lan ila\u00e7lara g\u00f6re daha ayr\u0131nt\u0131l\u0131 planlamam\u0131za olanak sa\u011fl\u0131yor. [1] Tedavi se\u00e7imi, hastal\u0131\u011f\u0131<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3776","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Metastatik Meme Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tansan.com.tr\/en\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Metastatik Meme Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi\" \/>\n<meta property=\"og:description\" content=\"Meme kanserinin ba\u015fka organlara yay\u0131lmas\u0131, hastalar ve yak\u0131nlar\u0131 i\u00e7in pek \u00e7ok soruyu beraberinde getirir. Bug\u00fcn tedavide hedefimiz, hastal\u0131\u011f\u0131 m\u00fcmk\u00fcn oldu\u011funca uzun s\u00fcre kontrol alt\u0131nda tutmak, ya\u015fam s\u00fcresini uzatmak ve ki\u015finin g\u00fcnl\u00fck ya\u015fam\u0131n\u0131 korumakt\u0131r. Son y\u0131llarda artan se\u00e7enekler, tedaviyi t\u00fcm\u00f6r\u00fcn \u00f6zelliklerine ve daha \u00f6nce kullan\u0131lan ila\u00e7lara g\u00f6re daha ayr\u0131nt\u0131l\u0131 planlamam\u0131za olanak sa\u011fl\u0131yor. [1] Tedavi se\u00e7imi, hastal\u0131\u011f\u0131\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tansan.com.tr\/en\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/\" \/>\n<meta property=\"og:site_name\" content=\"\u00d6zel Tansan Poliklini\u011fi\" \/>\n<meta property=\"article:modified_time\" content=\"2026-11-17T20:29:55+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tansan.com.tr\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/\",\"url\":\"https:\/\/tansan.com.tr\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/\",\"name\":\"Metastatik Meme Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi\",\"isPartOf\":{\"@id\":\"https:\/\/tansan.com.tr\/#website\"},\"datePublished\":\"2026-11-17T18:53:02+00:00\",\"dateModified\":\"2026-11-17T20:29:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/tansan.com.tr\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tansan.com.tr\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tansan.com.tr\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Ana sayfa\",\"item\":\"https:\/\/tansan.com.tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Metastatik Meme Kanseri Tedavisinde Yeni Geli\u015fmeler\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tansan.com.tr\/#website\",\"url\":\"https:\/\/tansan.com.tr\/\",\"name\":\"Tansan Onkoloji - \u00d6zel Tansan Poliklini\u011fi\",\"description\":\"Kanser Te\u015fhis ve Tedavisi\",\"publisher\":{\"@id\":\"https:\/\/tansan.com.tr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tansan.com.tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/tansan.com.tr\/#organization\",\"name\":\"\u00d6zel Tansan Onkoloji Poliklini\u011fi\",\"url\":\"https:\/\/tansan.com.tr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png\",\"contentUrl\":\"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png\",\"width\":274,\"height\":66,\"caption\":\"\u00d6zel Tansan Onkoloji Poliklini\u011fi\"},\"image\":{\"@id\":\"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Metastatik Meme Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tansan.com.tr\/en\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/","og_locale":"en_GB","og_type":"article","og_title":"Metastatik Meme Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi","og_description":"Meme kanserinin ba\u015fka organlara yay\u0131lmas\u0131, hastalar ve yak\u0131nlar\u0131 i\u00e7in pek \u00e7ok soruyu beraberinde getirir. Bug\u00fcn tedavide hedefimiz, hastal\u0131\u011f\u0131 m\u00fcmk\u00fcn oldu\u011funca uzun s\u00fcre kontrol alt\u0131nda tutmak, ya\u015fam s\u00fcresini uzatmak ve ki\u015finin g\u00fcnl\u00fck ya\u015fam\u0131n\u0131 korumakt\u0131r. Son y\u0131llarda artan se\u00e7enekler, tedaviyi t\u00fcm\u00f6r\u00fcn \u00f6zelliklerine ve daha \u00f6nce kullan\u0131lan ila\u00e7lara g\u00f6re daha ayr\u0131nt\u0131l\u0131 planlamam\u0131za olanak sa\u011fl\u0131yor. [1] Tedavi se\u00e7imi, hastal\u0131\u011f\u0131","og_url":"https:\/\/tansan.com.tr\/en\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/","og_site_name":"\u00d6zel Tansan Poliklini\u011fi","article_modified_time":"2026-11-17T20:29:55+00:00","twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tansan.com.tr\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/","url":"https:\/\/tansan.com.tr\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/","name":"Metastatik Meme Kanseri Tedavisinde Yeni Geli\u015fmeler - \u00d6zel Tansan Poliklini\u011fi","isPartOf":{"@id":"https:\/\/tansan.com.tr\/#website"},"datePublished":"2026-11-17T18:53:02+00:00","dateModified":"2026-11-17T20:29:55+00:00","breadcrumb":{"@id":"https:\/\/tansan.com.tr\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tansan.com.tr\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/tansan.com.tr\/metastatik-meme-kanseri-tedavisinde-yeni-gelismeler\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Ana sayfa","item":"https:\/\/tansan.com.tr\/"},{"@type":"ListItem","position":2,"name":"Metastatik Meme Kanseri Tedavisinde Yeni Geli\u015fmeler"}]},{"@type":"WebSite","@id":"https:\/\/tansan.com.tr\/#website","url":"https:\/\/tansan.com.tr\/","name":"Tansan Oncology - Tansan Private Polyclinic","description":"Cancer Diagnosis and Treatment","publisher":{"@id":"https:\/\/tansan.com.tr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tansan.com.tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/tansan.com.tr\/#organization","name":"Tansan Private Oncology Polyclinic","url":"https:\/\/tansan.com.tr\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/","url":"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png","contentUrl":"https:\/\/tansan.com.tr\/wp-content\/uploads\/2020\/02\/TansanLogo-1.png","width":274,"height":66,"caption":"\u00d6zel Tansan Onkoloji Poliklini\u011fi"},"image":{"@id":"https:\/\/tansan.com.tr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages\/3776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/comments?post=3776"}],"version-history":[{"count":2,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages\/3776\/revisions"}],"predecessor-version":[{"id":3796,"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/pages\/3776\/revisions\/3796"}],"wp:attachment":[{"href":"https:\/\/tansan.com.tr\/en\/wp-json\/wp\/v2\/media?parent=3776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}